-
1
-
-
0037417523
-
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
-
Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
-
(2003)
Lancet
, vol.361
, pp. 13-20
-
-
Keeley, E.C.1
Boura, J.A.2
Grines, C.L.3
-
2
-
-
16444368352
-
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials
-
De Luca G., Suryapranata H., Stone G.W., et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 293 (2005) 1759-1765
-
(2005)
JAMA
, vol.293
, pp. 1759-1765
-
-
De Luca, G.1
Suryapranata, H.2
Stone, G.W.3
-
3
-
-
0035927938
-
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction
-
Montalescot G., Barragan P., Wittenberg O., et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 344 (2001) 1895-1903
-
(2001)
N Engl J Med
, vol.344
, pp. 1895-1903
-
-
Montalescot, G.1
Barragan, P.2
Wittenberg, O.3
-
4
-
-
0036710545
-
Effect of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty
-
Zorman S., Zorman D., and Noc M. Effect of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty. Am J Cardiol 90 (2002) 533-536
-
(2002)
Am J Cardiol
, vol.90
, pp. 533-536
-
-
Zorman, S.1
Zorman, D.2
Noc, M.3
-
5
-
-
9644256044
-
Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion-results of the Austrian multi-centre randomized RoePro-BRIDGING study
-
Gyongyosi M., Domanovits H., Benzer W., et al. Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion-results of the Austrian multi-centre randomized RoePro-BRIDGING study. Eur Heart J 25 (2004) 2125-2133
-
(2004)
Eur Heart J
, vol.25
, pp. 2125-2133
-
-
Gyongyosi, M.1
Domanovits, H.2
Benzer, W.3
-
6
-
-
3242722762
-
Prehospital versus periprocedural administration of abciximab in STEMI: early and late results from randomised REOMOBILE study
-
Arntz H., Schroder J., Pels K., et al. Prehospital versus periprocedural administration of abciximab in STEMI: early and late results from randomised REOMOBILE study. Eur Heart J 23 (2003) 1502
-
(2003)
Eur Heart J
, vol.23
, pp. 1502
-
-
Arntz, H.1
Schroder, J.2
Pels, K.3
-
7
-
-
3242703683
-
Early administration of abciximab bolus in the emergency room improves microperfusion after primary percutaneous coronary intervention, as assessed by TIMI frame count: results of the ERAMI trial
-
Gabriel H.M., Oliviera J., da Silva P.C., et al. Early administration of abciximab bolus in the emergency room improves microperfusion after primary percutaneous coronary intervention, as assessed by TIMI frame count: results of the ERAMI trial. Eur Heart J 24 (2003) 268
-
(2003)
Eur Heart J
, vol.24
, pp. 268
-
-
Gabriel, H.M.1
Oliviera, J.2
da Silva, P.C.3
-
8
-
-
0027965764
-
Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction
-
Schroder R., Dissmann R., Bruggemann T., et al. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol 24 (1994) 384-391
-
(1994)
J Am Coll Cardiol
, vol.24
, pp. 384-391
-
-
Schroder, R.1
Dissmann, R.2
Bruggemann, T.3
-
9
-
-
0024723470
-
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms
-
Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
-
(1989)
J Am Soc Echocardiogr
, vol.2
, pp. 358-367
-
-
Schiller, N.B.1
Shah, P.M.2
Crawford, M.3
-
10
-
-
33744839368
-
A formula to estimate the approximate surface area if height and weight be known
-
DuBois D., and DuBois E.F. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 17 (1916) 863-871
-
(1916)
Arch Intern Med
, vol.17
, pp. 863-871
-
-
DuBois, D.1
DuBois, E.F.2
-
11
-
-
0021916187
-
The Thrombolysis in Myocardial Infarction (TIMI) Trial: phase I findings
-
TIMI Study Group
-
TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) Trial: phase I findings. N Engl J Med 312 (1985) 932-936
-
(1985)
N Engl J Med
, vol.312
, pp. 932-936
-
-
-
12
-
-
9044246670
-
TIMI frame count: a quantitative method of assessing coronary artery flow
-
Gibson C.M., Cannon C.P., Daley W.L., et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93 (1996) 879-888
-
(1996)
Circulation
, vol.93
, pp. 879-888
-
-
Gibson, C.M.1
Cannon, C.P.2
Daley, W.L.3
-
13
-
-
0033977923
-
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs
-
Gibson C.M., Cannon C.P., Murphy S.A., et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101 (2000) 125-130
-
(2000)
Circulation
, vol.101
, pp. 125-130
-
-
Gibson, C.M.1
Cannon, C.P.2
Murphy, S.A.3
-
14
-
-
0033133399
-
Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the glycoprotein receptor antagonist patency evaluation (GRAPE) pilot study
-
van den Merkhof L.F., Zijlstra F., Olsson H., et al. Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the glycoprotein receptor antagonist patency evaluation (GRAPE) pilot study. J Am Coll Cardiol 33 (1999) 1528-1532
-
(1999)
J Am Coll Cardiol
, vol.33
, pp. 1528-1532
-
-
van den Merkhof, L.F.1
Zijlstra, F.2
Olsson, H.3
-
15
-
-
0032705846
-
Effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: results of ReoMI pilot study
-
Makkar R., Goff B., Eigler N., et al. Effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: results of ReoMI pilot study. Catheter Cardiovasc Interv 48 (1999) 430-434
-
(1999)
Catheter Cardiovasc Interv
, vol.48
, pp. 430-434
-
-
Makkar, R.1
Goff, B.2
Eigler, N.3
-
16
-
-
27744567570
-
Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studies
-
Godicke J., Flather M., Noc M., et al. Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studies. Am Heart J 150 (2005) 1015.e11-1015.e17
-
(2005)
Am Heart J
, vol.150
-
-
Godicke, J.1
Flather, M.2
Noc, M.3
-
17
-
-
3142708764
-
Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis
-
Montalescot G., Borentain M., Payot L., et al. Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis. JAMA 292 (2004) 362-366
-
(2004)
JAMA
, vol.292
, pp. 362-366
-
-
Montalescot, G.1
Borentain, M.2
Payot, L.3
-
18
-
-
0343798542
-
Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group
-
Strategies for Patency Enhancement in the Emergency Department (SPPED) Group. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group. Circulation 101 (2000) 2788-2794
-
(2000)
Circulation
, vol.101
, pp. 2788-2794
-
-
Strategies for Patency Enhancement in the Emergency Department (SPPED) Group1
-
19
-
-
33748849090
-
Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial
-
Gibson C.M., Kirtane A.J., Murphy S.A., et al. Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial. Am J Heart 152 (2006) 668-675
-
(2006)
Am J Heart
, vol.152
, pp. 668-675
-
-
Gibson, C.M.1
Kirtane, A.J.2
Murphy, S.A.3
-
20
-
-
0035822603
-
Normal flow (TIMI 3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction. Analysis from the primary angioplasty in myocardial infarction trials
-
Stone G.W., Cox D., Garcia E., et al. Normal flow (TIMI 3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction. Analysis from the primary angioplasty in myocardial infarction trials. Circulation 104 (2001) 636-641
-
(2001)
Circulation
, vol.104
, pp. 636-641
-
-
Stone, G.W.1
Cox, D.2
Garcia, E.3
-
21
-
-
1942516993
-
Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty
-
De Luca G., Ernest N., Zijlstra F., et al. Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 43 (2004) 1363-1367
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 1363-1367
-
-
De Luca, G.1
Ernest, N.2
Zijlstra, F.3
-
22
-
-
32644466395
-
Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials
-
Keeley E.C., Boura J.A., and Grines C.L. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet 367 (2006) 579-588
-
(2006)
Lancet
, vol.367
, pp. 579-588
-
-
Keeley, E.C.1
Boura, J.A.2
Grines, C.L.3
-
23
-
-
0030754005
-
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators
-
Migrino R.Q., Young J.B., Ellis S.G., et al. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators. Circulation 96 (1997) 116
-
(1997)
Circulation
, vol.96
, pp. 116
-
-
Migrino, R.Q.1
Young, J.B.2
Ellis, S.G.3
-
24
-
-
0023219810
-
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction
-
White H.D., Norris R.M., Brown M.A., et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76 (1987) 44-51
-
(1987)
Circulation
, vol.76
, pp. 44-51
-
-
White, H.D.1
Norris, R.M.2
Brown, M.A.3
-
25
-
-
33644650062
-
Early abciximab administration in acute myocardial infarction treated with primary coronary intervention
-
Bellandi F., Maioli M., Leoncini M., et al. Early abciximab administration in acute myocardial infarction treated with primary coronary intervention. Int J Cardiol 108 (2006) 36-42
-
(2006)
Int J Cardiol
, vol.108
, pp. 36-42
-
-
Bellandi, F.1
Maioli, M.2
Leoncini, M.3
-
26
-
-
10944239058
-
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)
-
Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110 (2004) e82-e292
-
(2004)
Circulation
, vol.110
-
-
Antman, E.M.1
Anbe, D.T.2
Armstrong, P.W.3
|